You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an alternative browser.
You should upgrade or use an alternative browser.
-
Make it like cafepharma, but for different industries. Learn more about CompanyUnderground
anonymous
Guest
anonymous
Guest
If you are considering working here, don’t. They will say anything to get you in the door. Do not. Run.
anonymous
Guest
anonymous
Guest
Internal recruiters are posting TM positions as "an opportunity to break into medical sales" now
anonymous
Guest
anonymous
Guest
Internal recruiters are posting TM positions as "an opportunity to break into medical sales" now
can confirm. Not surprised though, the comp is barely in line with ASR’s in other companies/areas
anonymous
Guest
anonymous
Guest
Medtronic not attracting talent like they used to. Good talent has already left, looking to leave, and for those still here, miserable. Outdated products and people. Medtronic, taking the tech out of med tech.
Stock price recently is accurately reflecting the state of our business. Riding this bad boy down into the ground.
Stock price recently is accurately reflecting the state of our business. Riding this bad boy down into the ground.
anonymous
Guest
anonymous
Guest
Medtronic not attracting talent like they used to. Good talent has already left, looking to leave, and for those still here, miserable. Outdated products and people. Medtronic, taking the tech out of med tech.
Stock price recently is accurately reflecting the state of our business. Riding this bad boy down into the ground.
Stock price recently is accurately reflecting the state of our business. Riding this bad boy down into the ground.
anonymous
Guest
anonymous
Guest
Medtronic not attracting talent like they used to. Good talent has already left, looking to leave, and for those still here, miserable. Outdated products and people. Medtronic, taking the tech out of med tech.
Stock price recently is accurately reflecting the state of our business. Riding this bad boy down into the ground.
Stock price recently is accurately reflecting the state of our business. Riding this bad boy down into the ground.
anonymous
Guest
anonymous
Guest
They say 780 and G4 will win back all from competition because of the clinical data. I feel like that is an extremely false statement. Managers are scared and just riding it out. Comically the DMs that scolded the TMs are now hiding in the dirt. Any word on layoffs, performance management or division being sold?
anonymous
Guest
anonymous
Guest
They say 780 and G4 will win back all from competition because of the clinical data. I feel like that is an extremely false statement. Managers are scared and just riding it out. Comically the DMs that scolded the TMs are now hiding in the dirt. Any word on layoffs, performance management or division being sold?
They should lay your sorry ass off. You must really suck if you can’t sell 780/G4
anonymous
Guest
anonymous
Guest
anonymous
Guest
Good to see leadership is on here again. ^
That’s 100% a woke DM that has no clue what they’re doing because they haven’t sold shit since 530g or before, or hell maybe never sold any Medtronic pump/system. They’ll hire anyone these days.
anonymous
Guest
anonymous
Guest
Every time a new system is expected leadership predicts this is going to be the product that wins back the customers. Each time the product is an epic fail that is too hard to use while competitors produce easier to use devices. This time will be no different.
Always good clinical devices. But, competitors deliver what the customer expects and makes it simpler to use. Not pursuing Medicare coverage years ago for CGM was the proverbial straw that broke the camels back.
Medtronic diabetes is done. All the good reps that delivered high volume new pump sales have left the company.
Always good clinical devices. But, competitors deliver what the customer expects and makes it simpler to use. Not pursuing Medicare coverage years ago for CGM was the proverbial straw that broke the camels back.
Medtronic diabetes is done. All the good reps that delivered high volume new pump sales have left the company.
anonymous
Guest
anonymous
Guest
This division is so far removed from customer.
Embarrassing.
Embarrassing.
anonymous
Guest
anonymous
Guest
Has anyone seen dexcom g7? Direct from senior leadership- G7 is gonna smoke GS4….
guardian connect should be thrown in the trash.
guardian connect should be thrown in the trash.
anonymous
Guest
anonymous
Guest
Martha flagged shedding low performing businesses.... but he has put himself in a no win positiion by saying "its just around the corner". Everyone eventually says "i wish i would have dealt with it earlier"....
anonymous
Guest
anonymous
Guest
Martha flagged shedding low performing businesses.... but he has put himself in a no win positiion by saying "its just around the corner". Everyone eventually says "i wish i would have dealt with it earlier"....
He doesn't shed low performing business leaders so why expect he will shed entire businesses?
anonymous
Guest
anonymous
Guest
He doesn't shed low performing business leaders so why expect he will shed entire businesses?
Giving up on Renal Care comes before giving up on Diabetes
anonymous
Guest
anonymous
Guest
Which first, stock to $95 or a senior leader leaves for to pursue other interets?
anonymous
Guest
anonymous
Guest
He doesn't shed low performing business leaders so why expect he will shed entire businesses?
wouldn’t be the entire business, just diabetes US
anonymous
Guest
anonymous
Guest
They’ll wait to see if 780G and G4 will gain market share which I don’t think it will. Then they’ll say our next system will overtake competition. It’s the same thing over and over. Just sell the division already.